home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

198 rows where in_cev_map = 1, surface_class = "A_surface" and tier = "Tier 1.5" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: pdb_count_total, aptamer_count_pubmed

has_structure 2

  • 0 99
  • 1 99

has_known_aptamer 2

  • 0 158
  • 1 40

has_cryoEM 2

  • 0 150
  • 1 48

has_activation_state_pdb_pair 2

  • 0 197
  • 1 1

tier 1

  • Tier 1.5 · 198 ✖

surface_class 1

  • A_surface · 198 ✖

in_cev_map 1

  • 1 · 198 ✖
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P21359 NF1 Neurofibromin Tier 1.5 0.965 1 A_surface 26 87.19 1 0     1 2 32980430, 22617876 1 neurofibromatosis type 1 0.8844735398780649
P00813 ADA Adenosine deaminase Tier 1.5 0.957 1 A_surface 2 96.56 0 0     1 72 42012076, 41877526, 41762796, 41635914, 40403280, 40189053, 39856849, 39847085, 36796307, 33998617, 32043202, 30876536, 30060448, 27589406, 26606306, 25597304, 25521724, 25360869, 24976151, 24893272, 24682016, 24035856, 23462984, 23202335, 23037591, 22944024, 22613226, 41910181, 41791686, 41267360, 39673485, 39396299, 38583236, 36855421, 34241023, 33147453, 32546280, 30926472, 26605646, 24624989, 23373863, 22543727, 20345118, 19381549, 19378312, 18293985, 17440909, 17000903, 16856187, 16619330 1 Severe combined immunodeficiency due to adenosine deaminase deficiency 0.8556816060494579
P36021 SLC16A2 Monocarboxylate transporter 8 Tier 1.5 0.956 1 A_surface 7 79.56 1 0     0 0   1 Allan-Herndon-Dudley syndrome 0.8533069932022032
P51795 CLCN5 H(+)/Cl(-) exchange transporter 5 Tier 1.5 0.955 1 A_surface 2 80.62 0 0     0 0   1 Dent disease type 1 0.850724240157394
Q14524 SCN5A Sodium channel protein type 5 subunit alpha Tier 1.5 0.953 1 A_surface 16 67.25 1 0     0 0   1 long QT syndrome 3 0.8448298602976083
Q969N2 PIGT GPI-anchor transamidase component PIGT Tier 1.5 0.953 1 A_surface 3 87.25 1 0     0 0   1 multiple congenital anomalies-hypotonia-seizures syndrome 3 0.8439030764005646
P13637 ATP1A3 Sodium/potassium-transporting ATPase subunit alpha-3 Tier 1.5 0.953 1 A_surface 5 88.81 1 0     0 0   1 alternating hemiplegia of childhood 2 0.842328126568451
Q99250 SCN2A Sodium channel protein type 2 subunit alpha Tier 1.5 0.952 1 A_surface 5 68.81 1 0     0 0   1 developmental and epileptic encephalopathy, 11 0.8388748085806758
P25189 MPZ Myelin protein P0 Tier 1.5 0.951 1 A_surface 2 81.69 0 0     0 0   1 Charcot-Marie-Tooth disease type 1B 0.8377022197539885
Q9HAB3 SLC52A2 Solute carrier family 52, riboflavin transporter, member 2 Tier 1.5 0.95 1 A_surface 1 84.12 1 0     0 0   1 riboflavin transporter deficiency 0.8333271825486935
Q9Y653 ADGRG1 Adhesion G-protein coupled receptor G1 Tier 1.5 0.95 1 A_surface 1 77.88 1 0     0 0   1 bilateral frontoparietal polymicrogyria 0.8322298896713178
P36888 FLT3 Receptor-type tyrosine-protein kinase FLT3 Tier 1.5 0.949 1 A_surface 11 75.94 0 0     1 6 41733039, 34364920, 31434881, 30237882, 29299123, 22411871 1 acute myeloid leukemia 0.8313389209288576
P13473 LAMP2 Lysosome-associated membrane glycoprotein 2 Tier 1.5 0.948 1 A_surface 2 83.19 0 0     0 0   1 Glycogen Storage Disease Type 2b 0.8273010649608126
P14770 GP9 Platelet glycoprotein IX Tier 1.5 0.947 1 A_surface 2 84.69 1 0     0 0   1 Bernard-Soulier syndrome 0.8233582238860002
P16234 PDGFRA Platelet-derived growth factor receptor alpha Tier 1.5 0.945 1 A_surface 14 72.69 1 0     1 4 33334063, 32127469, 28010895, 30594071 1 gastrointestinal stromal tumor 0.8167494524079806
P51798 CLCN7 H(+)/Cl(-) exchange transporter 7 Tier 1.5 0.942 1 A_surface 9 80.94 1 0     0 0   1 Autosomal recessive malignant osteopetrosis 0.8065499095904218
Q96JI7 SPG11 Spatacsin Tier 1.5 0.937 1 A_surface 3 66.75 1 0     0 0   1 Autosomal recessive spastic paraplegia type 11 0.7886006646085494
Q8TD43 TRPM4 Transient receptor potential cation channel subfamily M member 4 Tier 1.5 0.936 1 A_surface 25 77.44 1 0     0 0   1 Familial progressive cardiac conduction defect 0.7868180621357534
P05023 ATP1A1 Sodium/potassium-transporting ATPase subunit alpha-1 Tier 1.5 0.936 1 A_surface 10 88.69 1 0     0 0   1 Charcot-Marie-tooth disease, axonal, type 2DD 0.7868851290226483
P04626 ERBB2 Receptor tyrosine-protein kinase erbB-2 Tier 1.5 0.934 1 A_surface 63 74.0 0 0     1 119 41836728, 41744190, 41540559, 41494763, 41413339, 41321156, 41297941, 40851486, 40761795, 40494827, 40403699, 40382399, 40223744, 40220375, 40120226, 40080161, 40056884, 39873777, 39809083, 39756158, 39748051, 39643321, 39609809, 39539244, 39263860, 39233482, 39177424, 38901393, 38813974, 38789508, 38693181, 38679242, 38604040, 38409854, 38066021, 37729138, 37659641, 37591183, 37522239, 37392577, 37038354, 36272296, 36255496, 36001395, 35504229, 34952586, 34476602, 34236165, 33876310, 33627408 1 non-small cell lung carcinoma 0.7789523142843545
P15529 CD46 Membrane cofactor protein Tier 1.5 0.934 1 A_surface 7 82.12 1 0     1 9 35114109, 34248841, 31761039, 31077760, 27734375, 19915929, 17046833, 11084032 1 atypical hemolytic-uremic syndrome with MCP/CD46 anomaly 0.7798469882597787
O94856 NFASC Neurofascin Tier 1.5 0.933 1 A_surface 2 76.31 0 0     0 0   1 neurodevelopmental disorder with central and peripheral motor dysfunction 0.7782432580663833
Q15746 MYLK Myosin light chain kinase, smooth muscle Tier 1.5 0.93 1 A_surface 7 65.88 0 0     0 0   1 aortic aneurysm, familial thoracic 7 0.7659842793171938
Q02094 RHAG Ammonium transporter Rh type A Tier 1.5 0.929 1 A_surface 8 95.62 1 0     0 0   1 Rh deficiency syndrome 0.764209214915708
P00846 MT-ATP6 ATP synthase F(0) complex subunit a Tier 1.5 0.928 1 A_surface 10 88.94 1 0     0 0   1 NARP syndrome 0.760749518172638
P24394 IL4R Interleukin-4 receptor subunit alpha Tier 1.5 0.923 1 A_surface 10 54.75 0 0     1 3 32751068, 27819142, 22282665 1 asthma 0.742115080702623
P25445 FAS Tumor necrosis factor receptor superfamily member 6 Tier 1.5 0.921 1 A_surface 7 77.88 1 0     1 17 40784034, 39897575, 37458448, 36908619, 35402075, 32270033, 31436946, 30594071, 30417194, 30339905, 26318819, 23980164, 23511245, 18997060, 18956014, 16729304, 16581027 1 autoimmune lymphoproliferative syndrome type 1 0.7377210386590284
P16671 CD36 Platelet glycoprotein 4 Tier 1.5 0.921 1 A_surface 1 93.94 0 0     1 6 41713143, 41140242, 39762152, 33596054, 33291667, 31904170 1 platelet-type bleeding disorder 10 0.7360571429413174
Q02413 DSG1 Desmoglein-1 Tier 1.5 0.92 1 A_surface 1 62.06 0 0     0 0   1 severe dermatitis-multiple allergies-metabolic wasting syndrome 0.7335328506238418
P09758 TACSTD2 Tumor-associated calcium signal transducer 2 Tier 1.5 0.919 1 A_surface 7 82.69 0 0     1 4 41384307, 41241473, 40050871, 39250993 1 gelatinous drop-like corneal dystrophy 0.7293087728162646
O15554 KCNN4 Intermediate conductance calcium-activated potassium channel protein 4 Tier 1.5 0.914 1 A_surface 17 84.19 1 0     0 0   1 dehydrated hereditary stomatocytosis 0.7145864899974032
O75110 ATP9A Probable phospholipid-transporting ATPase IIA Tier 1.5 0.914 1 A_surface 4 84.19 1 0     0 0   1 neurodevelopmental disorder with poor growth and behavioral abnormalities 0.7120328673255018
Q9NR82 KCNQ5 Potassium voltage-gated channel subfamily KQT member 5 Tier 1.5 0.913 1 A_surface 5 56.41 1 0     0 0   1 intellectual disability, autosomal dominant 46 0.7086662845211597
P08637 FCGR3A Low affinity immunoglobulin gamma Fc region receptor III-A Tier 1.5 0.912 1 A_surface 15 85.69 0 0     1 2 41249026, 21531729 1 autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity 0.7061437347032623
P51797 CLCN6 H(+)/Cl(-) exchange transporter 6 Tier 1.5 0.897 1 A_surface 3 77.81 1 0     0 0   1 neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities 0.6554030932062199
P21731 TBXA2R Thromboxane A2 receptor Tier 1.5 0.892 1 A_surface 6 86.25 1 0     0 0   1 bleeding diathesis due to thromboxane synthesis deficiency 0.639967145559869
Q13555 CAMK2G Calcium/calmodulin-dependent protein kinase type II subunit gamma Tier 1.5 0.891 1 A_surface 2 78.38 0 0     0 0   1 intellectual developmental disorder 59 0.6354497016986491
P02786 TFRC Transferrin receptor protein 1 Tier 1.5 0.887 1 A_surface 22 86.69 1 0     1 3 39831311, 29046922, 32527800 1 TFRC-related combined immunodeficiency 0.623449899069336
P54709 ATP1B3 Sodium/potassium-transporting ATPase subunit beta-3 Tier 1.5 0.88 1 A_surface 7 89.69 1 0     0 0   1 congestive heart failure 0.5999952111132625
Q92956 TNFRSF14 Tumor necrosis factor receptor superfamily member 14 Tier 1.5 0.879 1 A_surface 8 79.94 0 0     0 0   1 diffuse large B-cell lymphoma 0.5983171413833771
P01597 IGKV1-39 Immunoglobulin kappa variable 1-39 Tier 1.5 0.876 1 A_surface 2 90.5 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01764 IGHV3-23 Immunoglobulin heavy variable 3-23 Tier 1.5 0.876 1 A_surface 6 91.0 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01825 IGHV4-59 Immunoglobulin heavy variable 4-59 Tier 1.5 0.876 1 A_surface 3 91.56 1 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P23083 IGHV1-2 Immunoglobulin heavy variable 1-2 Tier 1.5 0.876 1 A_surface 1 91.75 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01593 IGKV1D-33 Immunoglobulin kappa variable 1D-33 Tier 1.5 0.876 1 A_surface 6 90.88 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P06312 IGKV4-1 Immunoglobulin kappa variable 4-1 Tier 1.5 0.876 1 A_surface 10 90.62 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P15954 COX7C Cytochrome c oxidase subunit 7C, mitochondrial Tier 1.5 0.868 1 A_surface 3 91.38 1 0     0 0   1 neurodegenerative disease 0.5589133210585959
P41440 SLC19A1 Reduced folate transporter Tier 1.5 0.866 1 A_surface 19 72.06 1 0     0 0   1 Knobloch syndrome 0.5526223217595396
Q96D96 HVCN1 Voltage-gated hydrogen channel 1 Tier 1.5 0.865 1 A_surface 2 69.75 0 0     0 0   1 Joubert syndrome 0.5504227269701596
Q9P1W8 SIRPG Signal-regulatory protein gamma Tier 1.5 0.864 1 A_surface 2 85.5 0 0     0 0   1 type 1 diabetes mellitus 0.5457344827318543

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 1150.09ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target